Stock Taper
ITGR
INTEGER HOLDINGS CORPORATION
NYSE
$126.61
▼ DOWN 0.03% (-0.04)

KEY STATISTICS

Market Cap$4.30 B
52w High$126.80
52w Low$62.00
Dividend Yield—
Frequency—
P/E19.94
Volume1.44M
Shares Out.33.95M

COMPANY

LEADERSHIP

Payman Khales
CHIEF EXECUTIVE
Payman Khales

COMPENSATION 2026

Salary$1,235,000
Stock Awards$5,999,951
Incentive Plan Pay$1,323,766
All Other Comp.$112,615
Total$8,671,332

ABOUT

SECTOR
Healthcare
WENT PUBLIC
September 29, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
11,000

PRICE TARGET

Target High$127.00
Target Low$104.00
Target Median$121.00
Target Consensus$118.25

UPCOMING EARNINGS

DateOct 22, 2026
DayThursday
Rev. Est.$456.91M
OCT
22
THU

ETFS HOLDING THIS STOCK

ETFS HOLDING
197
LISTED HERE
10
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
540
TOP 8 OF 540 · RANKED BY POSITION SIZE

PRICE

$126.61 ▼ DOWN 0.03% (−$0.04)
$127$127$127$1279:30 AM10:35 AM11:40 AM12:44 PM1:49 PM2:54 PM3:59 PM126.61

About Integer Holdings Corporation

https://www.integer.net ↗

Integer Holdings Corporation is a global medical device contract manufacturer offering products across cardiology, neuromodulation, orthopedics, surgical, and battery solutions for OEMs in healthcare, energy, military, and environmental markets.

INDUSTRY

Medical - Devices

A PRODUCT INTEGER HOLDINGS CORPORATION IS KNOWN FOR

Destino™ Twist Steerable Guiding Sheath
Destino™ Twist Steerable Guiding Sheath

The Destino™ Twist is a market-ready, deflectable steerable guiding sheath for electrophysiology, structural heart, and peripheral use, part of Integer's Oscor line, offering customizable solutions with regulatory clearance to accelerate medical d...

Integer Holdings in 2025

SENTIMENT: − NEGATIVE
Payman Khales
EARNINGS · OCTOBER 23, 2025

Integer Holdings Stock Plummets Over 30% After Slashing 2025 Guidance and Warning of Slow 2026 Growth

On October 23, 2025, alongside its Q3 earnings report, Integer Holdings Corporation lowered its full-year 2025 sales guidance and provided a weak forecast for 2026. The company cited the slower-than-anticipated market adoption of key new products, particularly in its electrophysiology (EP) portfolio, as the primary reason for the revision. This news triggered a severe negative reaction from investors, leading to a stock price collapse of over 32% in a single day and prompting multiple securities fraud class-action lawsuits.

PRODUCT STRATEGY · OCTOBER 2025 · ANNOUNCED

Integer Holdings Confronts Major Product Setback, Slashes Guidance Amid Faltering Electrophysiology Device Adoption

In a significant strategic setback, Integer Holdings Corporation was forced to lower its 2025 sales guidance and 2026 growth outlook due to the slower-than-forecasted market adoption of key new electrophysiology (EP) products. This unexpected weakness in a critical growth market triggered a more than 30% drop in the company's stock price and prompted a class-action lawsuit from investors.

Latest News

ZACKS INVESTMENT RESEARCH · OCT 7, 2026

Is the Options Market Predicting a Spike in Integer Holdings Stock?

Investors need to pay close attention to ITGR stock based on the movements in the options market lately.

EARLIER COVERAGE
DEFENSE WORLD · OCT 6, 2026

Analyzing SiBone (NASDAQ:SIBN) & Integer (NYSE:ITGR)

Integer (NYSE: ITGR - Get Free Report) and SiBone (NASDAQ: SIBN - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability and institutional ownership. Profitability This table compares Integer and SiBone's net margins, return

GLOBENEWSWIRE · OCT 2, 2026

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

PLANO, Texas, Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2026, and ending at the close of business on December 31, 2026. The Notes are convertible into cash, up to the principal amount of the Notes, and in cash, shares of the Company's common stock or a combination thereof, at the Company's election, in respect of the remainder, if any, of the Company's conversion obligation in excess of the aggregate principal amount of the Notes being converted.

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity3
Return On Assets5
Debt To Equity1
Price To Earnings2
Price To Book3
Overall Score3

MOST RECENT ANALYST GRADES

GRADE SUMMARY
HOLD 3
EQUAL WEIGHT 1
PERFORM 1
SECTOR WEIGHT 1
NEUTRAL 1
OVERWEIGHT 1
OUTPERFORM 1
9 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
HAE$118.28COMPARE
CON$36.80COMPARE
LIVN$75.84COMPARE
UFPT$292.13COMPARE
ADUS$115.35COMPARE
RXRX$3.87COMPARE
INSP$66.63COMPARE
AORT$21.39COMPARE

INSIDER TRADES

★
OFFICER: CHIEF HUMAN RESOURCES OFFICER
Thor Kirk K
Sale · 11.8K shares
2026-09-15
★
OFFICER: CHIEF HUMAN RESOURCES OFFICER
Thor Kirk K
Sale · 19.8K shares
2026-09-14
★
OFFICER: PRESIDENT, GROWTH & INNOVATION
Senn Andrew
Sale · 9.4K shares
2026-09-08
★
OFFICER: US - EVP, OPERATIONS
Metcalf Milo Stephen II
Purchase · 892 shares
2026-07-06